Eton Pharmaceuticals (ETON): Director filed to sell ~$5.34M
CASAMENTO CHARLES J, Director at Eton Pharmaceuticals, filed to sell ~$5.34M of Eton Pharmaceuticals shares.
- ~$5.34M
- planned to sell · 81K shares, around Nov 10, 2026
- Planned for
- Nov 10, 2026
- Notice filed
- Nov 10, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 6, 2026InsiderOfficer sold ~$229K of ETON shares in the open market
- Oct 14, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement“As disclosed in Item 1.01, on October 13, 2026, the Company entered into an exclusive license agreement and a supply agreement covering the United States and its territories for LIBERVANT® (diazepam) buccal film , an orphan-designated, differentiated treatment for seizure clusters in patients with epilepsy with Aquestive.”
- Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
- Nov 6, 20265% stakeOpaleye Management Inc. reported a passive stake (13G) of 8.5%
- Nov 10, 2026Insider · 2 peopleInsiders: 7 sales (~$5.6M)
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Eton Pharmaceuticals
For Eton Pharmaceuticals, OQRO holds 11 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ETON page.
How this filing works
Explore the data
Other disclosures at Eton Pharmaceuticals
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 10, 2026
Everything OQRO holds on this company is on its ETON page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
